The Lithuanian government has donated 50 thousand doses of Spikevax vaccine produced by Moderna company to Armenia as part of supporting third countries in the fight against the COVID-19 pandemic, the Armenian Ministry of Health reported.
“In consideration of Armenia’s request for assistance, the Ministry of Health of the Republic of Lithuania has been instructed to allocate, by 4 October 2021, 50,000 doses of Spikevax vaccine for humanitarian aid to Armenia out of the existing stock or out of planned purchases of COVID-19 vaccine doses under the Advance Purchase Agreement concluded between the European Commission and the pharmaceutical company Moderna on 25 November 2020. The transfer of humanitarian aid consignments to responsible authorities will be organized by the Ministry of Health in cooperation with the Ministry of Foreign Affairs,’ the government of Lithuania said.
‘I am glad that today we can share with the people of Armenia not only AstraZeneca, but also Moderna vaccines, as Armenians had to wait much longer than Lithuanian citizens for their jab,’ said Prime Minister Ingrida Šimonytė. She stressed that Lithuania will continue to share vaccines with countries that find it more difficult to obtain them than the EU member states.
This year, Lithuania has already donated 200,000 doses of Vaxzevria (AstraZeneca) vaccine to Ukraine, Moldova, Georgia, and Armenia, and 255,900 doses to Taiwan. It is the first time Lithuania is donating a Moderna-manufactured vaccine.
Lithuania will continue to contribute to the Team Europe initiative of the EU’s global efforts to manage the pandemic. The EU member states share vaccines with third countries through the COVAX Facility that helps the low- and middle-income countries obtain vaccines, as well as on a bilateral basis through the EU vaccine-sharing mechanism.
In Armenia, 4 types of Covid-19 vaccines are used now- CoronaVac and Sinofarm (China), AstraZeneka (Britain, Sweden) and Sputnik V (Russia). Vaccinations are free for people over 18 years old, including foreigners.